BioXgen, the medical device company developing the first cardiac patch specifically designed to prevent post-operative atrial fibrillation (POAF), has opened a Community Investment Round under ...
A new scheme aimed at reducing cardiovascular disease is being launched in Guernsey this April. ABCD, a free prevention, ...
In one large survey, researchers at the American Heart Association found that a third of US adults have experienced symptoms ...
Tom Nolan reviews this week’s research The bleeding risk in people taking apixaban was substantially lower than that of ...
Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a ...
One of the first clinical trials of these custom models suggests it might improve care for ventricular tachycardia, a notoriously difficult-to-treat arrhythmia that is a major cause of sudden cardiac ...
A former Ivy League student was days away from prison and deportation after being accused of a crime he insists never happened. Criminal court cleared him — but his university did not. He was expelled ...
Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...
Background Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic ...
Dietary supplements for diabetes are generally not recommended, but some research shows the benefits of using them to manage ...
Atrial fibrillation incidence remains stable across cardiovascular-kidney-metabolic syndrome stages 0 through 2, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results